Grifols Jumps as Exane Expects Increase in Plasma Pricing

Grifols SA, Europe’s largest maker of blood-plasma products, jumped the most in seven months after Exane BNP Paribas said the global market for protein therapies derived from the material will expand in the next two years.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.